Healthcare Realty Trust Incorporated (HR) P/E Ratio History
Historical price-to-earnings valuation from 1994 to 2022
Loading P/E history...
HR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Healthcare Realty Trust Incorporated (HR) trades at a price-to-earnings ratio of -28.5x, with a stock price of $20.24 and trailing twelve-month earnings per share of $-0.58.
The current P/E is 130% below its 5-year average of 96.0x. Over the past five years, HR's P/E has ranged from a low of 25.7x to a high of 233.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.3x, HR trades at a 217% discount to its sector peers. The sector includes 170 companies with P/E ratios ranging from 1.1x to 195.0x.
Relative to the broader market, HR trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $14B | 195.0 | - | -72% | |
| $41B | 160.4 | - | +184%Best | |
| $152B | 155.7 | - | -11% | |
| $14B | 23.7 | 1.02Best | +25% | |
| $94M | 115.3 | - | -95% | |
| $500M | 226.2 | - | +134% | |
| $4B | 24.5 | - | -4% | |
| $2B | 15.3Lowest | - | +24% | |
| $5B | 32.0 | - | +19% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
HR Historical P/E Data (1994–2022)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $19.27 | $0.31 | 63.1x | -10% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $20.85 | $0.72 | 28.9x | -59% |
| FY2022 Q2 | $27.20 | $0.62 | 44.0x | -37% | |
| FY2022 Q1 | $27.48 | $0.74 | 37.0x | -47% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $31.64 | $0.56 | 56.4x | -20% |
| FY2021 Q3 | $29.78 | $0.37 | 80.3x | +14% | |
| FY2021 Q2 | Wed Jun 30 2021 00:00:00 GM | $30.20 | $0.36 | 84.4x | +20% |
| FY2021 Q1 | Wed Mar 31 2021 00:00:00 GM | $30.32 | $0.26 | 117.2x | +67% |
| FY2020 Q4 | $29.60 | $0.24 | 122.3x | +74% | |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $30.12 | $0.15 | 195.2x | +178% |
| FY2020 Q2 | $29.29 | $0.14 | 203.0x | +189% | |
| FY2020 Q1 | $27.93 | $0.16 | 173.0x | +146% |
Average P/E for displayed period: 70.2x
See HR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HR vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonHR — Frequently Asked Questions
Quick answers to the most common questions about buying HR stock.
Is HR stock overvalued or undervalued?
HR trades at -28.5x P/E, below its 5-year average of 96.0x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does HR's valuation compare to peers?
Healthcare Realty Trust Incorporated P/E of -28.5x compares to sector median of 24.3x. The discount suggests lower growth expectations or higher risk.
What is HR's PEG ratio?
HR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1994-2022.